Insider · CIK 0001955231
Freebird Partners LP
Files at ERNA (Eterna Therapeutics Inc.), CMRA (Comera Life Sciences Holdings, Inc.). First filing -, latest -.
In brief
Freebird Partners LP files SEC Form 4 as 10% owner at ERNA (Eterna Therapeutics Inc.), and also at CMRA (Comera Life Sciences Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Freebird Partners LP has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 29, 2023 | CMRA Comera Life Sciences Holdings, Inc. | POpen-market purchase Convertible Note Sharesderivative | +2,453,636 | $0.06 | $135k | 2,453,636 | Jan 3, 2024 |
| Dec 29, 2023 | CMRA Comera Life Sciences Holdings, Inc. | POpen-market purchase Common Stock Purchase Warrantderivative | +4,907,272 | - | - | 7,362,005 | Jan 3, 2024 |
| Dec 14, 2023 | ERNA Eterna Therapeutics Inc. | DDisposition to issuer Common Stock Purchase Warrantderivative | +424,928 | - | - | 524,474 | Dec 18, 2023 |
| Dec 14, 2023 | ERNA Eterna Therapeutics Inc. | AGrant or award Common Stock Purchase Warrantderivative | +424,928 | - | - | 949,402 | Dec 18, 2023 |
| Dec 14, 2023 | ERNA Eterna Therapeutics Inc. | DDisposition to issuer Common Stock Purchase Warrantderivative | +524,474 | - | - | 424,928 | Dec 18, 2023 |
| Dec 14, 2023 | ERNA Eterna Therapeutics Inc. | AGrant or award Common Stock Purchase Warrantderivative | +524,474 | - | - | 949,402 | Dec 18, 2023 |
| Dec 15, 2023 | ERNA Eterna Therapeutics Inc. | POpen-market purchase Convertible Note Sharesderivative | +520,996 | $1.92 | $1000k | 783,233 | Dec 18, 2023 |
| Dec 15, 2023 | ERNA Eterna Therapeutics Inc. | POpen-market purchase Common Stock Purchase Warrantderivative | +1,041,992 | - | - | 1,991,394 | Dec 18, 2023 |
Questions about Freebird Partners LP
Answered from the filings on this page, as of the latest one.
Is Freebird Partners LP buying or selling?
Freebird Partners LP has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Freebird Partners LP's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Freebird Partners LP has 0.
Where does Freebird Partners LP file Form 4?
Freebird Partners LP has filed Form 4 at ERNA (Eterna Therapeutics Inc.); CMRA (Comera Life Sciences Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.